Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants.
Saved in:
| Title: | Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing Human Immunodeficiency Virus (HIV)-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants. |
|---|---|
| Authors: | Cunningham CK; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA., McFarland EJ; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Morrison RL; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Capparelli EV; University of California, San Diego, California, USA., Safrit JT; Elizabeth Glaser Pediatric AIDS Foundation, Washington District of Columbia, USA., Mofenson LM; Elizabeth Glaser Pediatric AIDS Foundation, Washington District of Columbia, USA., Mathieson B; Formerly at National Institutes of Health Office of AIDS Research, National Institutes of Health, Bethesda, Maryland, USA., Valentine ME; FHI 360, Durham, North Carolina, USA., Perlowski C; FHI 360, Durham, North Carolina, USA., Smith B; Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA., Hazra R; Maternal and Pediatric Infectious Disease Branch Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, USA., Purdue L; National Institute of Allergy and Infectious Diseases, Division of AIDS (Contractor), Bethesda, Maryland, USA., Muresan P; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Frontier Science Foundation, Brookline, Massachusetts, USA., Harding PA; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Mbengeranwa T; University of Zimbabwe College of Health Sciences-Clinical Trials Research Centre, Harare, Zimbabwe., Robinson LG; Children's Diagnostic and Treatment Center, Broward Health, Fort Lauderdale, Florida, USA., Wiznia A; Jacobi Medical Center, Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York, USA., Theron G; Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Lin B; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Bailer RT; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Graham BS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. |
| Corporate Authors: | IMPAACT P1112 team |
| Source: | The Journal of infectious diseases [J Infect Dis] 2020 Jul 23; Vol. 222 (4), pp. 628-636. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6613 |
|---|---|
| DOI: | 10.1093/infdis/jiz532 |
